InvestorsHub Logo
Followers 8
Posts 2087
Boards Moderated 0
Alias Born 07/31/2006

Re: JG36 post# 94592

Thursday, 07/17/2014 12:38:23 PM

Thursday, July 17, 2014 12:38:23 PM

Post# of 146240
NanoViricides has been hammered mercilessly for in the past publishing overly optimistic predicted timelines as to the approval process regarding their stable of drugs. So now, they're being hammered mercilessly for NOT offering a firm prediction relative to the beginning of TOX studies. Seems like some people want it both ways.

The company has explained the reasons for the delay in the commencement of the TOX, and those reasons are long-term very positive for the company's prospects. TOX studies are the next step toward FDA approval and licensing of their drugs, and TOX studies will at some point begin, hopefully soon now that the new facility will be able to greatly increase the rate at which test materials can be produced.


Best to all.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News